CA2025858A1 - Compose antihepatopathique - Google Patents

Compose antihepatopathique

Info

Publication number
CA2025858A1
CA2025858A1 CA2025858A CA2025858A CA2025858A1 CA 2025858 A1 CA2025858 A1 CA 2025858A1 CA 2025858 A CA2025858 A CA 2025858A CA 2025858 A CA2025858 A CA 2025858A CA 2025858 A1 CA2025858 A1 CA 2025858A1
Authority
CA
Canada
Prior art keywords
antihepatopathic
antihepatopathic composition
composition
useful
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2025858A
Other languages
English (en)
Other versions
CA2025858C (fr
Inventor
Shinji Ohmori
Kazumi Ogata
Takahiro Sakaue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of CA2025858A1 publication Critical patent/CA2025858A1/fr
Application granted granted Critical
Publication of CA2025858C publication Critical patent/CA2025858C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002025858A 1989-09-29 1990-09-20 Compose antihepatopathique Expired - Fee Related CA2025858C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP256370/1989 1989-09-29
JP1256370A JP2919870B2 (ja) 1989-09-29 1989-09-29 肝障害抑制剤

Publications (2)

Publication Number Publication Date
CA2025858A1 true CA2025858A1 (fr) 1991-03-30
CA2025858C CA2025858C (fr) 1999-03-23

Family

ID=17291746

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002025858A Expired - Fee Related CA2025858C (fr) 1989-09-29 1990-09-20 Compose antihepatopathique

Country Status (10)

Country Link
US (1) US5081149A (fr)
EP (1) EP0420224B1 (fr)
JP (1) JP2919870B2 (fr)
KR (1) KR970008107B1 (fr)
AT (1) ATE86117T1 (fr)
CA (1) CA2025858C (fr)
DE (1) DE69001004T2 (fr)
DK (1) DK0420224T3 (fr)
ES (1) ES2054186T3 (fr)
GR (1) GR3007219T3 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0469156B1 (fr) * 1990-02-17 1996-10-23 Senju Pharmaceutical Co., Ltd. Derive de glutathione
WO1991016065A1 (fr) * 1990-04-26 1991-10-31 Senju Pharmaceutical Co., Ltd. Inhibiteur de troubles hepatiques
US5212159A (en) * 1991-02-27 1993-05-18 Senju Pharmaceutical Co., Ltd. Anticataract composition
TW225992B (fr) * 1992-07-17 1994-07-01 Senju Pharma Co
CA2213266A1 (fr) * 1996-09-04 1998-03-04 Hideki Tsuruoka Methode d' isolement et de purification du s-(1,2-dicarboxyethyl)glutathion
US6350467B1 (en) * 1996-12-31 2002-02-26 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
JP5815364B2 (ja) 2010-10-26 2015-11-17 住友理工株式会社 メンバマウント及びその組付構造

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788945A (fr) * 1971-09-20 1973-03-19 Oreal
JPS638337A (ja) * 1986-06-30 1988-01-14 Senjiyu Seiyaku Kk 抗血液凝固剤
DE3722647A1 (de) * 1987-07-09 1989-01-19 Gerhard Ohlenschlaeger Galenische verwendung eines tripeptids als arzneimittel
JPH02255624A (ja) * 1989-03-29 1990-10-16 Senjiyu Seiyaku Kk 血小板凝集抑制剤
JP2815179B2 (ja) * 1989-07-14 1998-10-27 千寿製薬株式会社 抗炎症および／または抗アレルギー剤

Also Published As

Publication number Publication date
KR910005860A (ko) 1991-04-27
ES2054186T3 (es) 1994-08-01
GR3007219T3 (fr) 1993-07-30
DE69001004D1 (de) 1993-04-08
CA2025858C (fr) 1999-03-23
JPH03118334A (ja) 1991-05-20
ATE86117T1 (de) 1993-03-15
EP0420224B1 (fr) 1993-03-03
JP2919870B2 (ja) 1999-07-19
KR970008107B1 (ko) 1997-05-21
DE69001004T2 (de) 1993-07-15
EP0420224A1 (fr) 1991-04-03
US5081149A (en) 1992-01-14
DK0420224T3 (da) 1993-04-05

Similar Documents

Publication Publication Date Title
TW288011B (fr)
CA2009735A1 (fr) Composes nitro actifs comme insecticides
CA2171275A1 (fr) Derives du stilbene et compositions pharmaceutiques qui en renferment
CA2165819A1 (fr) Derives de dc-89
EP0219876A3 (en) Antihypertensive agents comprising 2-alkynyladenosines as active ingredients
FR2677982B1 (fr) Composes polyfluoroalkylthiopoly(ethylimidazolium), procede de preparation et leur utilisation comme agents biocides.
IE872329L (en) New cephem compounds and processes for preparation thereof
HUT61780A (en) Process for producing new peptides and pharmaceutical compositions comprising same as active ingredient
CA2171836A1 (fr) Mycophenolate mofetil anhydre cristallise; formulation intraveineuse a base de ce produit
CA2020474A1 (fr) Compose anti-inflammatoire ou antiallergique
CA2129542A1 (fr) Preparation pharmaceutique a base de rhamnolipide
CA2109435A1 (fr) Compositions d'acide n-(phosphonoacetyl)-l-aspartique et methodes pour leur utilisation comme agents antiviraux a large spectre
EP0786252A4 (fr) Agent antitumoral
GR3007401T3 (fr)
CA2025858A1 (fr) Compose antihepatopathique
EP0546177A4 (fr) Derive de benzopyrane, sa production, et composition pharmaceutique le contenant.
CA2204204A1 (fr) Derives de glucides
CA2118425A1 (fr) Derive du benzothiazolesulfamide, son mode de preparation et son utilisation
CA2112061A1 (fr) Composes alkyliques heterocycliques substitues
CA2111955A1 (fr) Nouveau compose tetracyclique
CA2025490A1 (fr) Alkyl piperidines subtituees et leur utilisation comme inhibiteurs de la synthese du cholesterol
GB9125970D0 (en) New compounds
IE893258L (en) New 2-carbonyl substituted n,n'-di-(trimethoxybenzoyl)¹piperazines, process for preparing the same and¹therapeutical compounds containing them
CA2052020A1 (fr) Derives de la pradimicine
CA2108710A1 (fr) Composition herbicide et methode de desherbage

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed